Mandate

Vinge has advised D. Carnegie & Co in connection with a bond issue of MSEK 1,000

April 19, 2016

Vinge has advised D. Carnegie & Co AB (publ) (”D. Carnegie”), listed on Nasdaq Stockholm, in connection with the company’s issue of senior unsecured bonds in the amount of MSEK 1,000 with a tenor of three years. D. Carnegie will apply for the bonds to be listed on Nasdaq Stockholm.

The proceeds from the issue, together with the proceeds from a share issue which was carried out on 5 April 2016, will be used for repayment of convertible subordinated loans (including payment of a market-based compensation for the option value related to the convertible subordinated loans) and a vendor note to Svensk Bolig Holding AB.

Vinge’s team consisted of Jesper Schönbeck, Mikael Ståhl, Sofie Bjärtun, Helena Håkansson and Josefine Larsson.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026